Abstract
Context.-RET gene fusions are oncogenic drivers in nonsmall cell lung cancer and nonmedullary thyroid cancer. Selpercatinib (RETEVMO), a targeted inhi......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
